Star Scientific, Inc. is a technology-oriented company with a mission to promote maintenance of a healthy metabolism and lifestyle. Since the incorporation of our Rock Creek Pharmaceuticals subsidiary in 2007, our research has focused primarily on the utility of anatabine, one of the alkaloids found in the Solanaceae family of plants, which includes tomatoes, eggplants, peppers, potatoes, and tobacco.  Initially, our research concentrated on the impact of anatabine in decreasing an individual’s desire to smoke cigarettes or use other traditional tobacco products. More recently, Rock Creek Pharmaceuticals has been focusing on the anti-inflammatory aspects of anatabine, in an effort to develop a range of non-nicotine dietary supplements and related pharmaceutical products that could be beneficial in maintaining a healthy metabolism and in supporting good nutrition.  Learn More

Click HERE to watch a replay of the March 20, 2014 Investor and Analyst Meeting.

Update Regarding FDA Warning Letter

The Food and Drug Administration (“FDA”) has informed Star Scientific that it intends to release the Company’s response to the Agency’s Warning Letter.  The Company’s response, which was filed on January 31, 2014, fully explains the position that Anatabloc® and CigRx® are legally on the market because anatabine is a substance that is present in the food supply in the same form as the ingredient in the Company’s supplements, and the products were on the market before any Investigational New Drug Application was filed for anatabine.  Because the letter will now be in the public record, the Company is making a copy of its response available on our website.  For a more complete explanation of the Company’s position with respect to the FDA Warning Letter, please click here to read the response in its entirety.

(345 KB)

Recent News
Mar 17, 2014
Star Scientific, Inc. (NASDAQ: STSI) today filed its annual report on Form 10-K with the Securities & Exchange Commission (SEC). In December 2013,...
Feb 14, 2014
Star Scientific, Inc., (NASDAQ: STSI) today announced that the Company will host an Analyst and Investor meeting for research analysts, and...
Feb 12, 2014
Star Scientific, Inc., (NASDAQ: STSI) announced today that Theodore Jenkins has joined the Company as Vice President, Corporate Strategy and...
Jan 10, 2014
Star Scientific, Inc., (NASDAQ: STSI) announced today that its conference call presentation announced on January 2, 2014, will be held at 4 p.m. ET...
Jan 2, 2014
Star Scientific, Inc., (NASDAQ: STSI) announced today that the Company will hold a conference call for investors on January 15, 2014, to discuss...
Dec 31, 2013
Star Scientific, Inc., (NASDAQ: STSI) announced that today it has entered into a Letter of Intent for a $15 million Credit Facility with Jonnie R....

Price Data
SEC Filings
Form Description Date Format
DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") Nov 18, 2013 HTMLDOCPDFXLS
10-Q Annual report which provides a comprehensive overview of the company for the past year Nov 12, 2013 HTMLDOCPDFXLSXBRL viewerXBRL download
8-K Report of unscheduled material events or corporate event Nov 8, 2013 HTMLDOCPDF